Journals / MN Kardiyoloji / 2001 / Cilt: 8 - Sayı: 4

Tumor necrosis factor-alpha in diastolic heart failure

Diyastolik disfonksiyonda tümör nekrozis faktör-alfa' nın rolü

Pages
247–249
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: We concluded that circulating TNF-alpha level is not increased in patients with diastolic dysfunction

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Elevated levels of circulating tumor necrosis factor-alpha (TNF-alpha) has been demonstrated in various heart disease including acute myocardial infarction, unstable angina pectoris, viral myocarditis and systolic heart failure.
📊
Key Findings & Data:MATERIAL AND METHODS: Forty hypertensive patients who have good left ventricular systolic function (ejection fraction >= 55% determined by echocardiographic examination using acustic quantification method) have been enrolled into the study.
💡
Conclusion & Impact:CONCLUSION: We concluded that circulating TNF-alpha level is not increased in patients with diastolic dysfunction
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ekokardiyografi · Tümör nekrozis faktör-alfa · Ventriküler disfonksiyon

Abstract

AIM: Elevated levels of circulating tumor necrosis factor-alpha (TNF-alpha) has been demonstrated in various heart disease including acute myocardial infarction, unstable angina pectoris, viral myocarditis and systolic heart failure. However there is no enough data in diastolic heart failure. In this study we investigated circulating levels of TNF-a in patients with pure diastolic heart failure. MATERIAL AND METHODS: Forty hypertensive patients who have good left ventricular systolic function (ejection fraction >= 55% determined by echocardiographic examination using acustic quantification method) have been enrolled into the study. Twenty of the patients (7 men, 13 women, mean age 59.2±10.6) have relaxation abnormality according to the mitral diastolic inflow pattern in echocardiographic examination (Group I) and 20 other patients (5 men, 15 women, mean age 45.9±7.9) have normal diastolic function (Group II). Circulating TNF-alpha levels were measured by ELISA method. RESULTS: Circulating TNF-a levels was found to be similar in both groups (62.1±46 pg/mL for group I and 48.7±51.4 pg/mL for group II, p=0.89). CONCLUSION: We concluded that circulating TNF-alpha level is not increased in patients with diastolic dysfunction

Özet

AMAÇ: Tümör nekrozis faktör-alfa'nın sistolik kalp yetmezliği, akut miyokart infarktüsü, kararsız angina pektoris, viral miyokardit gibi bazı kalp hastalıklarında yükseldiği gösterilmiştir. Ancak diyastolik kalp yetmezliğinde tümör nekrozis faktör-alfa ile ilgili yeterli bilgi mevcut değildir. Bu çalışmada diyastolik disfonksiyonu olan hastalarda tümör nekrozis faktör-a düzeyleri araştırıldı. GEREÇ VE YÖNTEM: Sistolik fonksiyonları normal olan (ejeksiyon fraksiyonu >=%55) 40 hipertansif hasta çalışmaya alındı. Ejeksiyon fraksiyonu akustik kuantifikasyon metodu kullanılarak ekokardiyografi ile hesaplandı. Bu hastaların 20'sinde (7 erkek, 13 kadın, yaş ortalaması 59,2 ± 10,6) transmitral akım örneklerine göre relaksasyon anormalliği saptandı (Grup I). Diyastolik fonksiyonları normal olan diğer 20 hasta ise (5 erkek, 15 kadın, yaş ortalaması 45,9 ± 7,9) kontrol grubu olarak alındı (Grup II). Tümör nekrozis faktör-a düzeyleri ELISA yöntemi ile ölçüldü. BULGULAR: Tümör nekrozis faktör-alfa düzeyleri her iki grupta benzer bulundu ( Grup I'de 62,1 ± 46 pg/mL, grup II'de 48,7 ± 51,4 pg/mL, p=0,89). SONUÇ: Diyastolik disfonksiyonu (relaksasyon anormalliği) olan hastalarda tümör nekrozis faktör-alfa artmamaktadır

🔖

Cite This Article

GÜRLEK, A., KILIÇKAP, M., DANDACHİ, R., DİNÇER, İ., TUTKAK, H., ORAL, D. (2001). Tumor necrosis factor-alpha in diastolic heart failure. MN Kardiyoloji, Cilt: 8 - Sayı: 4, 247–249. https://ajindex.com/articles/298056

References (12)

  1. Maury CPJ, Teppo AM. Circulating tumor necrosis factor-a (cachectin) in myocardial infarction. J Intern Med 1989; 225:333-336.
  2. Smith SC, Allen PM. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res 1992; 70:856-863.
  3. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994; 72:561-566.
  4. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323:236-241.
  5. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J 1991; 66:356-358.
  6. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumor necrosis factor a in severe congestive cardiac failure. Br Heart J 1993; 70:141-143.
  7. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-a in the adult mammalian cardiac myocyte. J Clin Invest 1993; 92:2303-2312.
  8. Krown KA, Yasui Y, Brooker M et al. TNF- a receptor expression in rat cardiac myocytes: TNF inhibition of L-type Ca2+ current and Ca2+ transients. FEBS Lett. 1995; 376:24-30. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 1998;274:R577-R595. Klein AL, Scalia GM. Disease of Pericardium, Restrictive Cardiomyopathy and Diastolic Dysfunction. In: Topol EJ, Ed. Textbook of Cardiovascular Medicine. Lippincott-Raven Publishers, Philadelphia 1998; 639-705.
  9. Feldman AM, Combes A, Wagner D et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000; 35:537-544.
  10. Deswal A, Bozkurt B, Seta Y et al. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, Etanercept) in patients with advanced heart failure. Circulation 1999; 99:3224-3226.
  11. Goldhaber Jl, Kim KH, Natterson PD, Lawrence T, Yang P, Weiss JN. Effects of TNF- a on [Ca2+]i and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol 1996; 271:H1449-H1455. DeMeules JE, Pigula FA, Mueller M, Raymond SJ, Gamelli RL. Tumor necrosis factor and cardiac function. J Trauma 1992.
  12. Cain BS, Meldrum DR, Dinarello CA et al. Tumor necrosis factor alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 199; 27:1309-1318.